Enhanced renal Smad7 is an underlying mechanism required for the treatment of TSF on down-regulating of TGF-β/Smad-mediated renal fibrosis and NF-κB-driven inflammation in type 2 diabetes in rats. Here, SMAD7 is linked to type 2 diabetes mellitus.